Diagnostics
The Fleming Initiative Partnership: advancing solutions The partnership between Cepheid and the Fleming Initiative amplifies visibility of antimicrobial resistance, elevating public awareness that AMR represents a genuine public health emergency. The Fleming Initiative’s close connections to the UK government help demonstrate the need for sustained healthcare investment and political support for tackling AMR. Perhaps most valuable is the opportunity to work with renowned researchers who combine their scientific expertise to tackle the implementation challenges. Clinical trials can demonstrate diagnostic test performance under controlled conditions. However, real- world settings prove more complex. Hospitals possess different layouts, workflows, staffing models, and patient populations, which make implementing solutions that performed well in clinical trials more daunting in real world environments. Through this partnership, feasibility challenges can be identified and addressed, real-world evidence of effectiveness can be generated, transmission dynamics across different settings can be examined, and health economic analyses that demonstrate true value can be conducted. The objective extends beyond proving rapid
and public health programmes. The critical phrase is ‘appropriate diagnostic
testing’. No single test works for all populations or all settings. A testing strategy succeeding in a high-resource urban hospital might fail in a lower-resource rural facility, even for identical disease. Context proves crucial. For antimicrobial resistance specifically, diagnostics play multiple critical roles. First, they inform individual patient management, ensuring the right person receives the right antibiotic at the right time. Second, they generate surveillance data forming the foundation of any effective, larger-scale containment strategy. Without accurate epidemiological data, efforts to combat AMR proceed without clear direction. This becomes particularly challenging in
molecular testing works; it encompasses understanding how to make it work in diverse healthcare environments, from urban teaching hospitals to rural facilities with limited resources.
The role of diagnostics in combatting AMR The Lancet Commission highlighted years ago that diagnostics has been historically underfunded relative to its potential impact. Appropriate diagnostic testing can fundamentally transform patient management
Decontamination
Operator Training Retention starts with recognition.
Accredited classroom training and competency checks can support development, reduce churn and
strengthen the case for progression. Get in touch to secure your
training date and empower your teams.
enquiries@allthingsdecontamination.co.uk Tel: 07495821101
Scan here! May 2026 I
www.clinicalservicesjournal.com 31
lower-resource settings where CPE prevalence may be high. When a large proportion of the population carries resistant organisms, universal isolation becomes impractical. Even in these challenging environments, diagnostics remain essential for gathering surveillance data and understanding transmission patterns, the first steps toward developing effective interventions.
A challenge we can meet The rise of CPE infections in England since
James Thew -
stock.adobe.com
t
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
